Innovative Diagnostic Technologies Braingaze specializes in cutting-edge digital health solutions that utilize patented eye movement analysis to detect and diagnose cognitive disorders such as ADHD and Alzheimer's disease, offering opportunities to collaborate with clinics and healthcare providers seeking advanced diagnostic tools.

Strategic Industry Partnerships The company's recent licensing agreement with Tris Pharma and participation in PepsiCo's Greenhouse Accelerator highlight its potential to expand into broader health and wellness markets, providing sales avenues through pharmaceutical and consumer health sectors.

Expanding Clinical Footprint With solutions already adopted by leading clinics and a focus on improving patient outcomes, Braingaze presents opportunities to develop partnerships with medical institutions and mental health clinics looking to enhance diagnostic and therapeutic services.

Funding and Growth Potential Having secured $1.6 million in funding and engaging in product launches across multiple platforms, Braingaze is positioned for growth and product expansion, creating opportunities for sales of their digital health applications and related services.

Technological Integration Leveraging advanced tech stacks such as AI, cloud services, and mobile app technology, Braingaze offers potential for collaborative development of integrated solutions tailored for healthcare providers, research institutions, and technology partners aiming to innovate within cognitive health monitoring.